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CHAPTER I 
INTRODUCTION 
Delineation of the sympathetic nervous component of cardiac con-
trol includes the description of the distribution of sympathetic nerve 
terminals in the myocardium. A number of methods have been used to 
assess sympathetic nerve density in the heart including electronmicro-
scopy, histochemical fluorescence, and chemical assay of tissue levels 
of norepinephrine. However, these studies have generally looked at the 
four chambers as being homogeneous in sympathetic nerve and catechola-
mine distribution, with any one small area presented as representative 
of the entire chamber. Special attention has been given to the sino-
atrial and atrioventricular nodes and, only very recently, to the con-
ductile tissues. A systematic, detailed investigation of a whole 
chamber has not been done. If there are significant differences in 
sympathetic nerve distribution within a chamber, the comparisons (cham-
ber-to-chamber or nodal tissue-to-chamber, etc.) that previous studies 
have made may not only be relatively uninformative but also may be 
invalid. For example, if the right atrial appendage was densely in-
nervated, a study that compared SA nodal tissue with the remaining 
right atrium could have a different conclusion if the appendage was 
included in the comparison than if it was not included. 
Part of the difficulty involved in looking at this problem is the 
1 
lack of an adequate tool. Electromicroscopy is at a disadvantage be-
cause sample sizes must be so small that investigation of an entire 
heart, or even an entire chamber, is prohibitive. Chemical analysis 
of norepinephrine levels, too, has had a weakness in sample flexibi-
lity because there was a minimum amount of tissue required for the 
analysis; and so, the detail in which a heart may be looked at was 
1 imited. 
In the present study, a radiotracer labelling technique is used 
to address the problem of sympathetic nerve distribution in dog right 
atrium. The sympathetic nerve terminals will take up and retain exo-
genous norepinephrine. With this as a basis, the sympathetic nerve 
terminals were labelled with H3-norepinephrine; and so, sympathetic 
nerve terminal density was expressed as radioactivity per unit weight 
of heart. Twenty consecutive sections of heart which included the 
entire right atrium and the interatrial system were examined. This 
technique allows comparison of any section of any size with any other 
s=ction of heart; i.e., there is unlimited sample size flexibility. 
Also, any single right atrium can be investigated totally and in great 
detail. 
2 
The distribution of tritium label was looked at in titally dener-
vated hearts also. Any label present in those hearts must be due to 
factors other than neuronal uptake. 
The fact that, after axonal lesioning, the terminals of that nerve 
will not take up exogenous norepinephrine implicates another use for 
this technique. That is, the detailed distribution of the terminals of 
3 
individual small cardiac nerves may be traced. If, after lesioning of 
a small cardiac nerve, the uptake of exogenous norepinephrine was seen 
to decrease below control in a specific region of the myocardium, that 
region must normally receive part of the nerve's distribution, assuming 
no anatomical variability between animals. Finally, yet another appli-
cation of this technique is possible due to the inherent sample flexi-
bility. Sympathetic nerve terminal density in very specific areas of 
choice could be investigated for its relationship to contractility and 
conduction velocity. 
CHAPTER II 
LITERATURE REVIEW 
A. The Correlation Between Innervation and Endogenous Norepinephrine 
The positive correlation between the density of sympathet1c in-
nervation of an organ and endogenous norepinephrine content is well 
established (25). Rexed and Euler (74) measured norepinephrine con-
tent of various cattle nerve extracts and found that the more unmyeli-
nated postganglionic sympathetic fibers the particular nerve contained, 
the higher its norepinephrine content. The lack of norepinephrine in 
bone marrow and placenta (76, 25) correlates with physiological evi-
dence that these tissues have no sympathetic innervation. Also, the 
study of different layers of blood vessel walls shows the correlation 
between norepinephrine content and adrenergic innervation (75). In 
guinea pig heart, Angelakos (2) found good agreement between findings 
of a chemical determination of norepinephrine level and a histochemical 
fluorescence estimation of the anatomical correlate, the postganglionic 
sympathetic nerve terminal, when all catecholamines were taken into 
account. 
Norepinephrine does not occur in the preganglionic sympathetic 
nerve fibers, and lesion of those nerves does not appreciably affect 
norepinephrine content of peripheral tissues (43). Euler (26), from 
indirect evidence, felt that norepinephrine is present in much higher 
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concentrations in the nerve terminals than in the pre-terminal axons. 
Falck and Torp (30) confirm this with histochemical fluorescence pro-
cedures. They found norepinephrine exclusively in the postganglionic 
sympathetic nerves and in very high concentrations in the terminal 
regions. The norepinephrine content of the axon has been estimated 
at 100-500 ug/g and that of the terminal at 10,000 ug/g (67). 
Burn (9, 10), from indirect evidence, was the first to suggest 
that uptake of exogenous catecholamine occurs in an organ. Whitby, 
5 
et al (93), found uptake of H3-norepinephrine in various cat organs to 
be in accordance with the richness of sympathetic nerve supply. Radio-
autographic evidence (95, 96) shows H3-norepinephrine to be localized 
in the postganglionic sympathetic nerve terminals of rat heart. How-
ever, Hamberger, et al (38), have shown that large doses of norepine-
phrine (0.5-1.0 mg/kg) result in re-appearance of fluorescence in pre-
viously reserpine-depleted rat iris and that uptake occurred not only 
in the terminals but also in the pre-terminal axons. Furthermore, a 
number of investigators have seen release of radiolabel with sympathe-
tic stimulation after H3-norepinephrine perfusion of the organ which 
indicates the exogenous norepinephrine is going into the endogenous 
store (43). 
B. Uptake of Exogenous Norepinephrine 
A detailed account of norepinephrine uptake has been given by 
Iversen (43). The uptake process can proceed until norepinephrine tis-
sue levels are twice the normal content. Uptake can continue against 
a concentration gradient of 10,000:1. The rate of uptake can be des-
cribed by Michaelis-Menten enzyme kinetics. The uptake process has 
both structure and stereochemical specificity favoring 1-norepineph-
rine uptake over other amines. 
Bhagat has done a recent characterization of the uptake process 
as follows: 
There are two steps involved, transport into the nerve terminal and 
binding into the norepinephrine stores. The first step, the axonal 
transport mechanism, requires Na+ and K+ and it appears that membrane 
ATPase is involved. The uptake into the storage granules, the second 
step, requires Mg2+ dependent ATPase activity. The former process is 
important for the termination of action of the transmitter, and the 
second is important for sequestration from metabolizing agents in the 
neuron, and so, for maintenance of catecholamine content. 
There is an excellent correlation between endogenous norepine-
phrine content of an organ and the amount of exogenous norepinephrine 
uptake that occurs in the organ. Kopin, et al (53), found the effi-
. f t t · f · h · c14 f th · 1 t · t b c1ency o ex rae 1on o norep1nep r1ne- rom e c1rcu a 1on o e 
related to endogenous norepinephrine concentrations in various rat 
tissues. H3-norepinephrine uptake and endogenous norepinephrine con-
tent of guinea pig heart were similarly related (13). Olson, et al 
(69), obtained similar results with histochemical fluorescence and 
radioisotopic methods of norepinephrine assay. Since Angelakos (2) 
had estab 1 i shed agreement between chemical norepinephrine determi na-
tions and fluorescence norepinephrine determinations, this is further 
testimony of the reflection of endogenous norepinephrine levels of 
6 
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exogenous uptake quantitation. Many structurally related amines may be 
taken up by the sympathetic nerves (43). Sachs and Jonsson (75) have 
found a high correlation between H3-metaraminol uptake and endogenous 
norepinephrine content in the same human right atrium. 
C. Synaptic Dynamics 
Ultimately, the uptake and retention of exogenous norepinephrine 
will depend upon synaptic dynamics. Whether varying levels of sympa-
thetic nerve activity alter uptake and/or retention of norepinephrine 
may threaten the validity of estimating anatomy of the cardiac sympa-
thetics, by means of radiolabelling, a method confounded by dynamic 
processes at the synapse. That there is tonic firing of sympathetic 
nerves to the heart is evidenced by reserpine 1s ability to deplete 
nerve terminals of that transmitter because reserpine mainly blocks re-
uptake of norepinephrine into the storage granules. However, tissue 
concentration of norepinephrine is seen to remain constant regardless 
of the state of sympathetic activity (5). Weiner and Rabadjya (91) 
stimulated guinea pig hypogastric nerve (5 sec/min for 1 hr) and found 
no change from control in vas deferens norepinephrine level. Thoa, et 
al (87), also stimulated guinea pig hypogastric nerve for one hour and 
found no change. There is histochemical evidence for the stability of 
terminal norepinephrine content in that, when Malmfors (61) stimulated 
the sympathetic nerves to the iris (10Hz for 80 min), only a very 
slight decrease in fluorescence was seen. In mouse heart, Olivero and 
Stjarne (68) saw no change in endogenous norepinephrine between control 
and mice that had been exposed to cold ( +3°C for 3, 8, 12, 16 hrs). 
One implication of this line of evidence is that both histochemical 
fluorescence and chemical assay of norepinephrine, and so, their ap-
plications to anatomy of cardiac sympathetic supply, are not influ-
enced by sympathetic nerve stimulation. 
8 
However, the radiotracer approach to investigation of the cardiac 
sympathetic distribution which is based on uptake and retention of exo-
genous norepinephrine may well be influenced by varying sympathetic 
activity especially if there are independent regional fluctuations in 
activity level. It is well known that the H3-norepinephrine that is 
taken up by organs is released by neural stimulation (40), and so, the 
amount of label retained in a region is dependent upon neural traffic to 
that area. Gillis (34) administered H3-norepinephrine to cats either 
one minute before or immediately after a thirty second period of 
stellate ganglion stimulation. He found that nerve stimulation im-
mediately before H3-norepinephrine injection increased total radioac-
tivity in the cat heart and that stimulation one minute after the in-
jection caused no change from control. It is interesting that the 
amount of norepinephrine secreted per nerve impulse is not constant. 
The amount increases with stimulation frequency as indicated by bio-
chemical data on short trains of nerve stimulation in cat spleen (84). 
The amount released per stimulus is subject to various feedback regu-
lators. The increased norepinephrine released after a blocka9e {8) has 
implicated that receptors, which some postulate are presynaptic (54, 
59), as a link in a local feedback inhibition of transmitter release 
during nerve activity (37). Hedqvist (39) has postulated that prosta-
9 
glandin E, released upon nerve stimulation, may moderate further nore-
pinephrine release. Both radioactive and fluorimetric measures of 
spleen venous effluent were decreased from control by 50 percent during 
splenic nerve stimulation after .8- 1.6 x 10-6M PGE2 infusion. 
Of course, norepinephrine release has an absolute requirement for 
extracellular calcium ion. In fact, sympathetic transmitter release, 
in the disinhibited state ( a blockade) appears to be a simple function 
of the calcium ion concentration in the medium (84). 
Since sympathetic stimulation can affect exogenous norepinephrine 
uptake and it will effect release after uptake, and since endogenous 
norepinephrine concentration does not reflect the level of neural acti-
vity, some other index must be used to estimate stability of a label in 
the tissue. This index is turnover rate. Using recovery of norepine-
phrine content after depletion, Spector, et al (82), estimate norepineph-
rine turnover at 10 - 15 percent of the total tissue content per hour 
in rat heart. Montenari, et al (65) estimate half life of H3-norepine-
phrine at 20 hours in rat and guinea pig heart and at 6 hours in mouse 
heart. 
The maintenance of constant norepinephrine concentration in the 
nerve terminal is achieved by reuptake and increased synthesis. Olivero 
and Stjarne (68), using rate of disappearance of H3-norepinephrine from 
mouse heart as an index of norepinephrine turnover, saw a moderate in-
crease in norepinephrine synthesis in mice exposed to cold. In other 
tissues, too, sympathetic nerve stimulation accelerates synthesis (28). 
However, Thoa (86) points out that re-uptake of norepinephrine appears 
10 
to be the more important of the two since when re-uptake is inhibited 
during nerve stimulation with phenoxybenzamine, there is a significant 
decrease; and when both are inhibited, the level drops to that seen 
with phenoxybenzamine alone. 
The storage of norepinephrine is multicompartmental. Two types 
of granular vesicles are found in the adrenergic nerve terminal. Small 
granular vesicles (500 ~diameter) and large granular vesicles (1000 ~ 
diameter) have been identified by electromicroscopy (41). Homogeni-
zation and centrifugation of tissues containing nerve terminals reveals 
a breakdown of vesicles into a 11 heavy 11 and 11 light 11 type. Electronmicro-
scopic analysis of gradient fractions shows a correlation between heavy 
and large granular vesicles and between light and small granular vesi-
cles (18). Turnover of norepinephrine vesicles has been estimated at 
three to five weeks life span by Dahlstrom (14), and forty hours by 
DePotter~ et al (19). The norepinephrine level of small granular vesi-
cles has been estimated as high as one molar (41). 
That an extravesicular, intraneuronal storage compartment may 
exist has long been indicated by the presence of norepinephrine in the 
soluble supernatant fraction after ultracentrifugation (43). If MAO 
inhibitors are given to suppress intraneuronal norepinephrine meta-
bolism, and reserpine is given to prevent granular uptake, exogenous 
norepinephrine is seen to accumulate in the axoplasm (71). The portion 
that normally is found in the axoplasm cannot be determined, the evi-
dence from ultracentrifugation may be an artifact produced by vesicular 
rupture (27). Also, most evidence points to exocytosis as the mechanism 
11 
of release of norepinephrine from the nerve terminals. The quantal 
nature of norepinephrine release supports this and counters the theory 
of direct release from the axoplasm (18). 
Since there is more than one store of norepinephrine, the ques-
tion of which one or ones are preferentially released (if any) arises 
in tracing the fate of H3-norepinephrine. When the vas deferens was 
incubated with c14-tyrosine, stimulation resulted in an effluent that 
had a threefold specific activity (CPM/ng) over tissue levels, implying 
that newly formed transmitter (c14-norepinephrine) is preferentially 
released (87). Dahlstrom and Haggendal (15), too, have found newly syn-
thesized or recaptured transmitter is preferentially released and that 
preferentially released in large, young granules that are the equiva-
lent of the small easily releasable pool. The half life for this was 
about t1velve hours. Furthermore, there appeared to be only partial 
exocytosis of these granules. 
As previously mentioned, Gillis (34) found significant effects of 
nerve stimulation on uptake if temporal conditions were right. Other 
studies have shown decreased uptake during prolonged stimulation in 
salivary gland and vas deferens. Finally, one study reported no effect 
of nerve stimulation on uptake. Regardless, there remains no conceptu-
al necessity to exclude uptake during secretion by exocytosis (80). 
D. Extraneuronal Uptake 
Norepinephrine levels do not decline to zero after surgical dene-
rvation (25) which Euler interpreted as a result of incomplete surgical 
denervation. There is another explanation, however. At least part of 
12 
the remaining norepinephrine may be bound in extraneuronal stores. 
Fischer, et al (32), first found evidence for extraneuronal binding in 
rat submaxillary salivary glands. With perfusion of a solution with 
high norepinephrine content (1-40 ug/ml), Iversen (42) discovered an 
extremely rapid uptake which could not be explained by Uptake1, the 
neuronal uptake mechanism. He postulated a second uptake mechanism, 
Uptake2, that is extraneuronal. 
The precise location of extraneuronal storage sites is still 
debatable. Jacobowitz (45} reported that there were chromaffin cells 
in cat atrial ganglia, which he stated could be considered part of the 
extraneuronal catecholamine pool. This topic of catecholamine binding 
in specific granules of atrial muscle cells is a current research 
problem that has produced conflicting data (6, 17). Papka (70) reports 
that the 11 Chromaffin cells 11 that Jacobowitz (45) identified are similar 
to SIF (small intensely fluorescent) cells~ which are non-chromaffin 
(24), and to 11 granule containing cells 11 of atria. Papka found clusters 
of SIF cells arcund blood vessles in fetal and neonatal rabbit hearts. 
The regions around the coronary sinus and the fossa ovale have been 
found to contain many SIF cells (23). Using combined fluorescence and 
electronmicroscopy, Ellison and Hibbs (23) identified SIF cells as the 
same as granule containing cells by virtue of their similar locations. 
However, Angelakos, et al (3), with a word of caution about specificity 
of the histochemical fluorescence method, could find no SIF or catecho-
lamine containing cells in the heart. The fluorescent cells he found 
had fluorescence spectra distinctly different from those of catechola-
II 
1.
1, 
•I 
13 
mines and stated that it was likely that these contained serotonin or 
another indolamine. 
Perfusion of guinea pig hearts with high concentrations of nore-
pinephrine results in uptake in cardiac muscle, arterial smooth muscle, 
connective tissue fibers, and interstitial cells (fibroblasts) in addi-
tion to adrenergic nerves (46). Extraneuronal uptake had been seen by 
others in cardiac muscle and connective tissue of atria (22, 31, 61), 
and in coronary arteries (11). More recently, Lindmar and Loffelholz 
(56), using histochemical fluorescence, located efflux of norepinephrine 
from four compartments; the vascular space, the extracellular space, an 
extraneuronal compartment and an axoplasmic compartment. 
If fibroblasts are truly one of the sites of binding of norepi-
nephrine, the observation of these in the proximity of adrenergic vari-
cosities fits nicely with Iversen's (44) suggestion that Uptake2 is 
part of a mechanism for disposal of norepinephrine after neuronal re-
lease. Lightman and Iversen (55) report Uptake2 operates at all con-
centrations and norepinephrine is rapidly metabolized after this uptake. 
So, the function of Uptake2 could be termination of transmitter action 
by 11 uptake-and-metabolism 11 as opposed to 11 uptake-and-retention 11 as in 
adrenergic nerve terminals. Finally, it is important to note that defi-
nite species differences are observed for rate of uptake of H3-isopre-
nalins, an amine that is not taken up by adrenergic nerves, and so, is 
only taken up by extraneuronal stores (89). 
E. Surgical Denervation and Reinnervation 
Surgical sympathectomy results in Wallerian degeneration of sym-
14 
pathetic postganglionic nerves (62, 90). This is accompanied by levels 
of norepinephrine in the denervated organ that approach zero. Potter, 
et al (73), found normal norepinephrine levels, in dog heart, via chemical 
assay, to be RA:2.36 ug/g, RV:0.75 ug/g, LA:l.42 ug/g, LV:0.66 ug/g and 
whole heart: 0.74 ug/g. The average value was 0.009 ug/g for ten dener-
vated dog hearts. Furthermore, after H3-norepinephrine injection, nor-
mal heart contained RA:66.7 muCi/g, RV:83.4 muCi/g, LA:58.6 muCi/g, LV: 
134.0 muCi/g. Denervated hearts contained RA:B.O muCi/g, RV:8.9 muCi/g, 
LA:7.4 muCi/g, LV:8.2 muCi/g indicating that uptake and/or retention is 
drastically reduced in dog hearts. Spann, et al (81), found that cardiac 
surgical denervation reduced norepinephrine concentrations from 2.13 ug/g 
to 0.006 ug/g in cat right ventricle. There is evidence from histochemi-
cal fluorescence of cat nictitating membrane (92) which showed previous 
fluorescence to be gone four days after denervation. Van Orden, et al 
(90), also studied cat nictitating membrane and showed a positive cor-
relation between endogenous norepinephrine and the number of granular 
vesicles at various times after denervation. They showed also that de-
clining H3-norepinephrine uptake and declining number of intact nerve 
endings are well correlated. Peiss, et al (72), measured total catecho-
lamines after various surgical denervation procedures in dog heart and 
found levels ranging from 0.00 ug/g to 0.25 ug/g in the functionally un-
responsive hearts. Kaye, et al (49), found norepinephrine levels in dog 
hearts of 2.00 ug/g in right atrium, 1.03 in right ventricle, .66 in left 
ventricle. Peripulmonary dissection produced norepinephrine decreases 
to less than 25 percent of control in both right and left atrium. 
I 
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Spurgeon, et al (1975), looked at the conductile and contractile tissues 
and found significant reductions approaching zero in denervated dog 
hearts. 
The data concerning the temporal progress of reinnervation is con-
flicting. McGoodall (60) performed cervico-stellate ganglionectomy in 
sheep and followed the progress of cardiac reinnervation. He found that 
after six weeks, the norepinephrine levels approached control. Euler 
and Purkhold (29) found the progressive reinnervation of other sheep 
organs to be much slower, having followed the process up to four months 
after denervation. However, a heart is more difficult to denervate com-
pletely than other organs, and so, the differences may be due to the de-
gree of denervation that existed (88). Ebert and Sabiston (21), using 
the mediastinal neural ablation technique of Cooper, et al (12), found 
dog heart catecholamines reduced from .74-.90 ug/g to .09 ug/g four 
months after surgery. At eight months, the level was .12 ug/g, at 12 
months it was .10 ug/g, and after 18 months the catechol amine level had 
only risen to .14 ug/g. Weiner, et al (92), studied the return of flu-
orescence in denervated cat nictitating membrane. They saw no visible 
fluorescence, implying no adrenergic reinnervation up to 38 days after 
den ervat ion. 
There are many functional studies, using responses to nerve stimu-
lation to evaluate reinnervation. Willman, et al (94), using this ap-
proach, found total denervation by autotransplantation, to persist in dog 
heart as long as 11 months. The myocardial catecholamine has returned 
11
to normal levels" (.58 ug/g) after 12 months. However, only two dogs 
16 
were checked for reinnervation between 6 months and 10 months, and no 
explanation was given of times at which dogs were checked before that. 
Peiss, et al (71), studied two dogs at 26 and 74 days after cardiac 
autotransplantation and found significant vagal reinnervation in the 
former and, in the latter, evidence of some reinnervation by both sym-
pathetic and parasympathetic fibers. Kontos, et al (52) studied rein-
nervation in cardiac homotransplanted and autotransplanted dogs and 
found no heart rate responses to stellate stimulation from 3 weeks to 
3 months after operation in the 5 dogs studied, but after 3 months all 
dogs studied had positive responses. Kondo, et al (51), studied rein-
nervation in the monkey and the dog after cardiac transplants. Sympa-
thetic reinnervation in the monkey began to show up at 60 days, but only 
one animal was tested prior to that time. Sympathetic reinnervation in 
the dog was reported to begin after 30 days, but only two dogs were 
tested prior to that time. 
F. Canine Cardiac Norepinephrine Distribution 
Norepinephrine distribution in dog heart has been assessed in seve-
ral ways by many investigators. Shore, et al (79), found norepinephrine 
levels in the atria which averaged 2.7 ug/g to be significantly higher 
than those found in the ventricles. They found that the portion of the 
right atrium which includes the SA node wat not significantly different 
from other atrial samples (2.3 ~ .5 ug/g vs. 2.7 ~ 1.0 ug/g). However, 
they do not describe the anatomical location of their samples in any 
detail. Their study also finds right atrial appendage norepinephrine 
level (2.4 ~ .4 ug/g) to be no higher than the other parts of the atrium. 
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However, a critical question arises over their methodology, since all 
animals were killed by pentobarbitone overdose or by exsanguination 
before the hearts were removed. A massive dose of this barbituate would 
take at least five minutes to kill the animal. The very real possibility 
that the mYOcardial depression and typical shock syndrome seen in either 
of these deaths (35) is partially due to depletion of cardiac norepineph-
rine leaves the validity of those means of sacrifice in question. How-
ever, Friedman and Bhagat (33) using the same method as Shore, et al 
found dog atrial norepinephrine levels of 2.98 ~ .17 ug/g and ventri-
cular levels of 1.09 ~ .02 ug/g, which are very close to Shore•s. 
In dogs under pentobarbital anesthesia, Klouda (50), using a tri-
hydroxyindole fluorimetric method, found dog right atrium norepinephrine 
averaging 1.46 ug/g. Anton and Sayre (4), using a modified fluorimetric 
assay, found a dog heart norepinephrine level of l .01 ug/g. It was not 
mentioned if this was whole heart or a sample and, if so, from which 
part of the heart. Serrano, et al (77), found norepinephrine levels to 
be no higher in the SA node region than in the atrium; however, they did 
find higher levels of epinephrine in this region. Schindler, et al (78), 
found a higher norepinephrine concentration in SA node than in the re-
mainder of the right atrium (which remainder excluded the appendage). 
The difference was significant (p ~ .005), but inconsistent, with five 
of 21 dogs having norepinephrine levels higher in the right atrial rem-
nant than the SA node. Their right atrial norepinephrine level (1.38 
ug/gm) agrees with Klouda (l .46 ug/g) but is lower than that of Shore, 
et al (2.7 ug/g). 
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Angelakos (1) found no difference between SA node region (1.44 ~ 
.20 ug/g) and the other tissue of the right atrium (1 .09 ~ .44 ug/g). 
Also, dopamine was two to three times higher in the SA nodal area (1.33 ~ 
.24 ug/gm) than the remainder of the right atrium (45 ~. 18 ug/gm). 
Angelakos, et al (3), histochemical analysis of dog heart reveals are-
latively dense network of fluorescent fibers in both SA node and AV node 
which is at variance with chemical norepinephrine determinations. He has 
been criticized on the basis of a lack of differentiation between norepi-
nephrine and dopamine in his technique. It is also puzzling that this 
method revealed no difference in density of nerve fibers between most of 
the areas of the ventricles and the atria. Chemical determinations con-
sistently report significant differences between the atria and ventricles. 
However, the fluorescence intensity of dog ventricle was markedly lower 
than that of the atria which they felt may indicate a lower intraneuronal 
norepinephrine concentration in the ventricle. Dahlstrom~ et al (16), 
also used a histochemical technique in dog heart. They found a high den-
sity of adrenergic nerves in the SA node, AV node, "upper part" of the 
right atrium~ and the right auricular trabeculae. Arterioles and venules 
were surrounded by a dense adrenergic plexus. 
Kaye, et al (49), measured norepinephrine levels in normal and par-
tially denervated dogs. Control right atria norepinephrine concentration 
was 2.00 ~ .16 ug/g. Recently, Spurgeon, et al (83), measured control 
norepinephrine levels of 1.0 ug/g in right atrium, l.l ug/q in SA node, 
and .4 ug/g in AV node. 
CHAPTER III 
MATERIALS AND METHODS 
A. The Denervation Procedure 
Eight of the eighteen dogs used in this study were subjected to 
a surgical, total, cardiac, denervation procedure. They were anesthe-
tized with sodium pentobarbital (25 mg/Kg, i.v.). The operation was per-
formed under aseptic conditions through a left thoracotomy. Control mea-
surements of ECG changes with individual stimulation of right and left 
thoracic vagi (20 Hz, 5 msec duration, 7 volts) and left stellate gan-
glion (10Hz, 5 msec duration, 7 volts) were made. The stimulating el-
ectrode was always tested on skeletal muscle to insure proper functioning. 
The test stimulations were repeated at the end of the operation to check 
for total denervation. At the time of right atrium removal, the right 
and left cervical vagi (20 Hz, 5 msec, 7 volts) and right and left stel-
late anterior ansae (10 Hz, 5 msec, 7 volts) were stimulated individually 
to reaffirm total cardiac denervation. 
A section of ventrolateral cervical cardiac nerve (as designated 
by Mizeres, (64), was excised from inside the pericardium. A peripulmo-
nary dissection of the adventitia was performed about one centimeter dis-
tal to the pulmonary valve. The pericardium was cut from the pulmonary 
artery to the SVC, exposing the azygous vein which was isolated, ligated, 
and cut. The pericardial cut was carried around the SVC. The area be-
tween the SVC and the superior lobe branch of the right pulmonary artery 
19 
i 
I 
20 
was dissected free from adventitia. This dissection was carried medially 
from the pulmonary artery branch along the superior border of the right 
atrium. If test nerve stimulations showed residual innervation at this 
time, a small fat pad at the junction of the inferior right atrium and 
the inferior vena cava was removed. Dogs were sacrificed two to four 
weeks post-operatively. 
B. Removal and Sectioning of the Right Atrium. 
Right atria from fed mongrel dogs (18-26 Kg) of both sexes were 
used. Both control and previously denervated dogs were anesthetized 
with phencyclidine HCL (2.0 mg/Kg) and alpha chloralose (80 mg/Kg). A 
tracheotomy and thoracotomy were performed with deliverance of adequate 
respiratory support. A slow injection into the superior vena cava (SVC) 
of 5 uCi/Kg of L-norepinephrine-H3 (Amersham-Searle, Arlington Heights, 
Illinois) was given over a period of five minutes. Two batches of the 
H3-norepinephrine were used; specific activities 7.2 Ci/mM and 4.24 Ci/mr~. 
After twenty minutes, as per Iversen (43), the whole heart was removed 
and rinsed in cold 0.9 percent sodium chloride solution. The right atrium 
was cut away from the right ventricular free wall. Next, the right atrial 
appendage was sectioned along its fold from the ventricular border to the 
SVC with care taken that the entire SA node was always left in the same 
part of the atrium. The interatrial septum was cut away from the left 
atrium. Finally, a cut at the septal tricuspid valve border freed the 
right atrium from the remaining heart. Figure 1 is a photograph of the 
interior of the right atrium before sectioning. The atrium was cut into 
twenty sections. Figure 2 shows the sectional layout of the right atrium. 
1'. 
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FIGURE 1 
THE INTERIOR OF THE RIGHT ATRIUM BEFORE SECTIONING 
2 
3 
FIGURE 2 
SECTIONAL LAYOUT OF THE RIGHT ATRIUM (AS SEEN FROM THE INTERIOR) 
4 5 6 7 12 
16 17 
13 14 15 
8 
9 
Sections 1 and 20 represent the apex of the appendage. The inter-
atrial septum includes Sections 13 and 14. The anterior free wall 
includes Sections 4 through 11 and the posterior free wall Sections 
15 through 18. 
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The fossa ovalis is located in Section 14, the coronary sinus in Section 
13. The tip of the atrial appendage is comprised of Sections 1, 2, 3, 
19, 20. 
No decisive localization of the nodal tissues or preferential con-
ductile pathways was done. However, based upon expert descriptions of 
where they should be, they can be estimated. The SA node should be in 
Section 5; the anterior internodal pathway within Sections 13 and 14; 
the middle internodal pathway in Sections 5, 6, 7, 13, 14; and the pos-
terior internodal pathway in Sections 5, 6, 7, 12, 13, 14. 
All visible fat was trimmed from each heart section. The sections 
were frozen before preparation for liquid scintillation counting. 
C. Sample Preparation for Counting 
Thawed sections of right atrium were weighed on a Roller-Smith 
balance which is accurate to .1 mg. The samples varied from about 100 
to 500 mg. The samples, which had been kept on ice, were ground in a 
Waring Blendor micro-attachment with 5 ml of .4N perchloric acid (4). 
After grinding for three minutes, each section was centrifuged at 4000 
x g for ten minutes in an International Portable Refrigerated Centrifuge 
(Model PR-2). One ml of the supernatant was added to 9 ml of PCS solu-
bilizer (Amersham-Searle Corporation, Arlington Heights, Illinois). 
D. Liquid Scintillation Counting 
The samples were counted in a Searle-Analytic Isocap/300 system. 
A quench correction curve was run with each group of samples counting 
efficiencies varied between 35% and 40%. The sample channels ratio me-
thod of quench correction was used. Determination of sample stability 
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was assessed by repetition of counting after up to a one week interim. 
Background counts were measured. 
E. Data Analysis 
The calculation of the H3-norepinephrine content of the sample in 
DPM/g was made according to the following formula: 
DPM/ = 50 (sam le CPM - background CPM) 
g {% efficiency x 10-2) (sample weight 
All data were analyzed for statistical significance using one-way 
analysis of variance followed by a Scheffe test for multiple group com-
parisons. Due to the great variation in total uptake from dog to dog 
and because the purpose of this study is to investigate relative densi-
ties within the atrium, normalized data were analyzed also. In that 
case, the data were expressed as percent of maximum for that particular 
heart. 
CHAPTER IV 
RESULTS 
A. Distribution of 3H-Norepinephrine Uptake 
Figure 3 shows mean DPM/g for each section and means of data ex-
pressed as percent of maximum for ten control dogs. In general, a gra-
dient, from high to low, runs from either tip of the right atrial ap-
pendage (Numbers 1, 20) to the interatrial septum (Numbers 13, 14). 
Also, the means of the upper anterior free wall (Numbers 4 through 7) 
are consistently higher than those of the lower anterior free wall 
(Numbers 8 through 11). Considering the standard deviation, the SA 
nodal section (Number 5) does not appear higher than those around it 
(Numbers 3, 4, 6, 7, 8, 9, 10). 
Table 1 shows the comparison of each section with every other sec-
tion for both raw and normalized data from the ten control dogs. The 
table contains the F ratios obtained from a Scheffe test which followed 
a one-way analysis of variance. Comparisons using raw data in DPM/gm 
show Section 1 was higher than Sections 7 (p<.005), 8 (p<.lOL 9 through 
11 (p<.005), 12 through 15 (p<.OOl), 16 and 17 (p<.025), and 18 (p<.Ol). 
There was no significant difference between Section 1 and Sections 2, 6 
and 19, 20. Section 2 was significantly higher than 11 (p<.05), 12 
(p<.10), 13 and 14 (p<.025), 15 (p<.05). Section 20 was higher than 7 
(p<.lO), 10 (p<.lO), 11 (p<.005), 12 (p<.Ol), 13 and 14 (p<.OOl), 15 
(p<.005). No other comparisons of raw data were significantly different. 
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FIGURE 3 
DISTRIBUTION OF RADIOACTIVITY IN NORMAL HEARTS 
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Solid bars are DPM/g. Striped bars are normalized as percent 
of maximum. Thin lines represent the standard deviation (N=lO). 
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TABLE 1 
MULTIPLE GROUP COMPARISONS OF NORMAL DOG HEART SECTIONS I 
I Section 1 
3.42 
2 2 
5.47 
12.15 2.68 
I' 3 3 
21.22 5.43 
l'i 
19.32 6.48 0. 83 
4 4 
34.12 12.26 1.16 
p <.025 
17.78 5.60 0.58 0.03 5 5 33.41 11.84 1.04 0.00 p<.025 
21.67 7.87 1.37 0.07 0.19 6 6 36.85 13.92 1.69 0.05 0.08 p<.025 
43.76 22.70 
7 p< .005 
9. 79 4.93 5.75 3.84 
75.96 40.66 15.02 8.26 8.62 7.00 p<.OOl p .005 
The F ratio for each sectional comparison is listed first. The 
lower number is the F ratio obtained when normalized data were used. 
Level of confidence was indicated only if the comparison was significant. 
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TABLE 1, CONTINUED 
Section 1 2 3 4 5 6 
28.00 11.85 3.26 0.80 1.16 0.41 
8 p <. 10 
49.69 22.18 5.08 1.46 1. 61 0.96 
p<.OOl 
40.03 20.04 8.07 3.73 4.45 2. 79 
9 p<.005 
70.73 36.85 12.81 6.60 6.92 5.41 
p<.001 p<.025 
43.14 22.26 9. 50 4. 72 5.53 3.66 
10 p< .005 
75.70 40.46 14.91 8.18 8.53 6.92 
p ~001 p <.005 
55.29 31.20 15.60 9.24 10.36 7.73 
11 p <.005 p <.05 
101.54 59.86 27.05 17.94 18.46 16.07 
p <, 001 p <, 001 
53.95 30.74 15.62 9.41 10.50 7.92 
12 p <.001 p <. 10 
89.97 51.96 22.61 14.44 14.90 12.79 
p <, 001 p <,001 
62.70 36.82 19.64 12.41 13.70 10.65 
13 p<.OOl p <.025 
111 . 31 67.42 32.06 22.18 22.76 20.07 
p<.001 p<.OOl p<.05 
59.44 34.34 17.84 10.99 12.20 9.33 
14 p<,001 p< .025 
106.21 63.46 29.42 19.93 20.48 17.94 
p<.OOl p<.OOl p<. 10 
I 
li, 
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TABLE 1, CONTINUED 
Section 2 3 4 5 6 
55.78 31.56 15.86 9. 44 10.57 7.91 15 p< .001 p <.05 
97.27 56.60 24.92 16.17 16.67 14.38 p <. 001 p <.001 
36.88 18.74 7.76 5. 72 4.40 2.83 I: 16 p <.025 
57.88 29.19 9.43 4.41 4.66 3.55 
l': 
p <.001 p <.1 0 
37.76 18.45 7.07 3.06 3. 72 2.22 17 p <.025 
70.73 36.85 12.81 6.60 6.92 5.47 p <.001 p <.025 
39.16 19.43 7.68 3.47 4.17 2. 57 18 p <,01 
74.11 39.30 14.23 7.66 8.00 6.44 
I', 
p <,001 p <,01 
7. 77 0.88 0.49 2.59 2.04 3.49 19 
16.67 3.04 0.40 3.09 2.88 3.95 
1.16 0.60 5.80 
20 
11.00 9.85 12.80 
2.20 0.73 10.01 18.99 18.46 21.04 
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TABLE 1, CONTINUED 
Section 7 
l. 75 
8 8 
2.78 
0.08 1.07 
9 9 
0.09 1.85 
0.00 1.63 0.06 10 10 
0.00 2.73 0.08 
0.67 4. 60 1.23 0.75 ll ll 1.85 9. 17 2.78 1.89 
0.82 4. 82 1.41 0.91 0.01 12 12 1.00 6.89 1.69 1.03 0. 10 
l. 70 6.90 2.53 1.82 0.23 0. 13 13 
3.37 12.26 4.58 3.42 0.22 0. 61 
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TABLE 1 , CONTINUED 
Section 7 8 9 10 11 12 
1.20 5.85 1.91 1.30 0.08 0.03 14 
2.53 10.61 3.59 2.58 0.05 0.30 
0. 73 4.74 1.30 0.81 0.00 0.01 15 
1.32 7.92 2. 11 l. 35 0.05 0.01 
I 
I 
0.03 1.17 0.01 0.01 0.88 1.03 16 
I 
0.37 0.93 0.10 0.35 3.58 2.38 
0.22 0.73 0.03 0.18 1.67 1.86 
1: 
17 
0.09 1.85 0.00 0.08 2.78 1.69 
II 
0.13 0.93 0.00 0.10 1.39 1.57 I' 
II 
18 
0.01 2.43 0.04 0.01 2.15 1.22 ~~~ 
14.65 6.27 12.53 14.29 21.61 21.46 I 19 21 .47 8.80 18.73 21.32 35.93 30.38 
1ll p .025 p • 10 
! 30.66 17.76 27.55 30.14 40.42 39.42 20 p <, 10 p <. 10 p <.005 p <.01 
1
11 
52.31 30.98 47.98 52.09 73.85 64.67 p <. 001 p <.05 p <. 001 p <.001 p <.001 p <, 001 
'I jill 1
11 
1
111' 
Ill\ 
Ill[ 
1/\, lllrll~~ 
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TABLE 1, CONTINUED 
Section 13 I 
0.04 I 
II 14 14 0.06 
r/ 0.20 0.06 1~1 15 15 
l'i 0.47 0.20 
II 1.94 1.43 0.94 
16 16 
rl 
5.47 4.45 2.86 
3.15 2.45 l. 75 0.08 
!! 17 
4.58 3.59 2. 11 0.10 
1'1 2.76 2.11 1.47 0.03 
18 
II 3. 77 2.88 1.57 0.26 
II 26.33 24.23 21 . 91 11 . 87 ~~I 19 41 .83 38.73 33.41 14.13 ~I p< .005 p<.01 p <.025 
46.79 48.98 40.84 25.57 i~l 20 p< .001 p<.001 p<.005 82.22 77.84 70.21 38.56 
1\1, p<.001 p<.001 p<.001 p<.01 
,1111 
Ill 
1
1illlli: II,! 
II'': 
II: 
lrJI 
I!'' II( 
'II, 
II 
11::,, 
II : Ill ~ 
:IIIII I 
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TABLE 1 , CONTINUED 
Section 17 
0.01 
18 18 
0.04 
11 0 27 12.04 
19 19 
18.73 20.48 
25.67 26.83 2.92 
20 
47.98 50.77 6. 76 
p<.001 p<.001 
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In general, the only significant differences were between the appendage 
sections (1, 2, 19, 20) which had the highest DPM/g and the sections 
other than the appendage. Comparisons using normalized data, in percent 
of maximum, show all previously significant differences. However, more 
of the comparisons were significant. Section 1 was significantly higher 
than 4 through 6 (p<.025), 7 through 18 (p<.OOl). Section 2 was higher 
than 7 (p<.005), 9 (p<.025), 10 (p<.005), 11 through 15 (p<.OOl), 16 
(p<.lO), 17 (p<.025), 18 (p<.Ol). Section 3 was higher than 13 (p<.05), 
14 (p<.lO). Section 19 was higher than ll (p<.025), 12 (p<.lO), 13 
(p<.005), 14 (p<.Ol), 15 (p<.025). Section 20 was higher than 7 (p<.00l), 
8 (p<.05), 9 through 15 (p<.OOl) and 16 (p<.Ol), 17 and 18 (p<.OOl). 
B. Distribution of Radioactivity in Denervated Hearts 
The denervated dogs were tested for the extent of cardiac dener-
vation, at the time of sacrifice, as explained in the methods. 
Figures 4 and 5 show test stimulations of right stellate and right 
cervical vagus and of left stellate and left cervical vagus in a dener-
vated dog at the time of sacrifice. No pacemaker shifts or rate effects 
were seen in the three lead ECG. 
Figure 6 shows mean DPM/g for each section and means of data ex-
pressed as percent of maximum for eight denervated dog hearts. There is 
no consistent gradient across the atrium in either the raw data or the 
normalized data. A Scheffe test was applied to the data from denervated 
hearts after a one-way analysis of variance. No section DPM/g was sig-
nificantly different from any other section in either the raw data or 
normalized data analysis. 
FIGURE 4 
TEST STIMULATIONS OF RIGHT STELLATE ANTERIOR ANSAE (RSS) 
AND RIGHT CERVICAL VAGUS (RCV) 
FOR TOTAL DENERVATION 
ECG RSS 
-
• 1 1 1 1 1 1 1 1 1 1 1 I 1 I I 1 1 1 1 r 1 1 II r.--' -~rv-' .,.,...·~·',\>~\"'""''""' ,,.,..:., .·, ,, \t", ,,._,, .. •, ·:.·, "': ,,.:r.r' ~".'('"'V''. •.r-,""'\~' •-', (·,...,~ •-....,..! \} ,!\ 
RCV 
Duration of the stimulus is indicated by the thick bar. 
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FIGURE 5 
TEST STIMULATIONS OF LEFT CERVICAL VAGUS (LCV) 
AND LEFT STELLATE ANTERIOR ANSAE (LSS) 
FOR TOTAL DENERVATION 
ECG LCV 
LSS 
Duration of stimulation is indicated by the thick bar. 
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FIGURE 6 
DISTRIBUTION OF RADIOACTIVITY IN DENERVATED HEARTS 
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Solid bars are DPM/g. Striped bars are normalized~ as percent 
of maximum. Thin lines represent the standard deviation (N=8). 
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C. Grouped Data 
Data from the sections were combined such that there were five 
larger sections. The sectional layout of these large sections is 
shown in Figure 7. Section l is comprised of Numbers l, 2, 3, 19, 20 
and represents the right atrial appendage. Section 2 is the upper an-
terior free wall (Numbers 4, 5, 6, 7). Section 3 is the lower anterior 
free wall (8, 9, 10, ll). Section 4 is the interatrial septum (13, 14). 
Section 5 is the dorsal free wall (16, 17, 18). 
Group comparisons of raw data are shown in Table 2. The numbers 
are F ratios from the Scheffe test. The appendage was higher than any 
other grouped section (p<.Ol). The interatrial septum appears lower 
than the upper anterior free wall (p<.Ol). 
Table 3 shows the results of the Scheffe test when normalized data 
were grouped as described for the raw data. Again the appendage group 
is significantly higher than any other group (p<.Ol). Also, the upper 
anterior free wall is higher than both the lower anterior free wall and 
posterior free wall (p<.Ol), and than the interatrial septum (p<.05). 
However, the interatrial septum is not lower than either the posterior 
free wall or the lower anterior free wall. 
A Scheffe test was applied to denervated data than were grouped in 
the same manner. Comparisons of the raw data gave an overall F ratio of 
0.49 (degrees of freedom= 4,146} which was not significant at the 5 per-
cent level of confidence. 
FIGURE 7 
SECTIONAL LAYOUT OF GROUPED SECTIONS 
Section 1 represents appendage; Section 2, upper anterior free 
wall; Section 3, lower anterior free wall; Section 4, inter-
atrial septum; Section 5, posterior free wall. 
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TABLE 2 
MULTIPLE COMPARISONS OF RAW DATA FROM GROUPED SECTIONS 
1 
2 38.96 2 
p <.01 
3 82.76 7.34 3 
p <.01 
4 91.04 19.21 4.71 
p <. 01 p <.0 1 4 
5 86 . 89 9 . 06 0. l1 3 . 52 
p <.01 
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TABLE 3 
MULTIPLE COMPARISONS OF NORMALIZED DATA 
FROM GROUPED SECTIONS 
1 
61 .48 
p <.01 
133.78 
p <. 01 
147.53 
p <.01 
139.33 
p <.01 
2 
12.61 3 
p <.05 
32.12 7.67 4 
p <.01 
15.11 0.15 5.91 
p <.01 
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CHAPTER V 
DISCUSSION 
The results indicate that the greatest uptake of 3H NE in the dog 
right atrium is to the tip of the appendage. This is an important reve-
lation because it explains one of the discrepancies found in the litera-
ture concerned with regional cardiac norepinephrine levels. Many in-
vestigators of dog right atrium (1, 3, 7, 8, 83} have reported no sig-
nificant elevation of norepinephrine content in the SA node over the re-
maining right atrium using chemical norepinephrine determinations. How-
ever, Shindler, et al (78), reported higher norepinephrine in SA node 
after Angelakos, et al (2), showed a dense histochemical fluorescence 
there. Shindler did not include the appendage in his right atrial com-
parison with the SA node, which in light of this study could have made 
the difference. 
It is interesting to note that Shore (79) made separate compari-
sons between appendage, right atrial ''portion containing SA node," and 
right atrium without SA node, and found no differences in NE concentra-
tion between these regions. However, his method of sacrifice (exsangui-
nation or pentobarbitone overdose) makes the data suspect, if they are 
to be considered normal levels. Also, the amount of right atrium in-
cluded in the portion containing the SA node was not defined, so that 
there is a possibility that extranodal tissue may be masking the level 
in the SA node. Furthermore, the study reports a concentration of 3.1 ug 
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norepinephrine/g for the atria (pooled), yet no measurement of any smaller 
area included in the atria exceeds 2.8 ug norepinephrine/g. 
The literature also holds confirmation of the present finding of 
significant sympathetic innervation of the appendage. Dahlstrom, et al 
(16), applied fluorescence microscopy to the dog right atrial appendage 
and found 11 a fairly large number of bundles of catecholamine nerve ter-
minals11 that ran parallel and close to muscle cells. Nielsen and Owman 
(66), in a histochemical fluorescence study of the thirteen lined ground 
squirrel heart, found density of innervation to increase in the atrial 
appendages. Angelakos, et al (2), found rabbit and guinea pig appendage 
(2.66 ug/g) to have a higher norepinephrine level than the body of the 
atrium (1.47 ug/g). 
Intuitively, the greater the detail in which the right atrium is 
scrutinized. the less likely it is that significant differences would be 
seen between any two regions. So, the abruptness of change in innervation 
could be reflected by the number of differences that remain with increasing 
detail (i.e., smaller sections). This borne out by grouping of twenty 
small sections into five larger ones. After grouping, additional dif-
ferences appear. The interatrial septum contained significantly lower 
norepinephrine concentrations than did the upper anterior free wall in 
the grouped analysis. However, if one small section of interatrial sep-
tum is compared with any small section of upper anterior free wall, no 
difference is indicated. 
The proportion of exogenous norepinephrine that will be taken up 
by an organ, after intravenous infusion, depends upon the relative 
~---------~ 
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abundance of sympathetic innervation of the organ and, also, upon the per-
cent of the cardiac output the organ receives. Within an organ, then, 
the amount of H3-norepinephrine that is taken up by any region is a 
function of the density of sympathetic innervation and also of the re-
gional flow. Thus, before it can be stated positively that differences 
in regional norepinephrine uptake in right atrium reflect differences in 
sympathetic supply, the contribution of differences in perfusion must be 
defined. Because Love and Burch (57) have reported that rate of regional 
perfusion varies from chamber to chamber and also from area to area within 
each chamber, it is reasonable to expect regional differences in per-
fusion. 
To generalize James' comparison of dog versus human coronary cir-
culation, there is far less anatomical variation from subject to subject 
in canine coronary anatomy than that of human. So, the fact that the 
gradient of H3-norepinephrine uptake in control dogs was consistent from 
dog to dog makes regional coronary flow even more important in view of 
the anatomical stability in the canine coronary circulation. 
The dog right atrium receives its blood supply from branches of 
the right coronary artery. The SA node is supplied by a branch that is 
larger than the others that come from the right coronary artery. It 
leaves the distal half of the right coronary artery, crosses with the 
sulcus terminalis to the SA node and eventually anastamoses with atrial 
branches from the circumflex artery. The relative size of this branch 
would, if anything, tend to present the SA node with a greater proportion 
of the blood flow. This would exaggerate the estimate of SA nodal 
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sympathetic supply based on H3-norepinephrine uptake. One or two small 
branches leave the right coronary, distal to the departure point of the 
branch to the SA node, which supply the area of the coronary sulcus. The 
right atrial appendage receives its supply of blood from one or two small 
branches that leave the right coronary artery proximal to the branch to 
the SA node. The ventral interatrial septum is supplied by the first 
branch from the circumflex artery, which also supplies the left atrium. 
This branch is the largest of the right atrial branches. It may encircle 
the SVC and anastamose with the right coronary branch to the SA node and 
may be the main supply to the SA node. Two or more other small branches 
from the circumflex supply the right atrium (63}. 
The multitude of blood supply routes to the right atrium makes 
blood flow estimation extremely difficult. And so, the question of pre-
ferential regional perfusion in the atrium is without an answer. However, 
there have been attempts to investigate regional flow using radiolabelled 
microspheres or Rb86 . Domenech, et al (20)~ using the microsphere method, 
compared dog right atrial "free wall" and interatrial septum and found 
no indication of differences in flow. Based on these observations, the 
low number of counts found in the interatrial septum cannot be due to a 
paucity of perfusion. Unfortunately, there is no more detailed com-
parison of regional right atrial flows. Such comparisons are essential 
to define the contribution of regional flow to the distribution of label. 
However, part of the variation in H3-norepinephrine uptake from dog to 
dog may be a function of individual differences in total coronary blood 
flow, since that is known to vary greatly. 
l 
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Even the data derived from the denervation experiments may contain 
a component of coronary flow changes in it. Gregg, et al (36), found 
circumflex artery flow, at rest, was about half that in surgically de-
nervated conscious dogs as compared with normal conscious dogs. If this 
trend applies generally to the coronary flow of the anesthetized dog, 
a decrease in H3-norepinephrine uptake in denervated dog heart would 
be expected. Whether reported regional differences in myocardial per-
fusion are a consequence of neural influences is not known. However, 
if this is the case, neural ablation would be expected to equilibrate 
the regional perfusion, and so, no regional differences in H3-norepi-
nephrine uptake expected due to the perfusion component of uptake would 
be seen. In fact, no regional differences in radioactivity were found 
in the 8 denervated dog hearts. 
A very important complication remains in the denervated heart data. 
That is, denervated coronary vessels presumably develop a supersensiti-
vity to catecholamines which would generally decrease coronary blood flow 
in denervated over normal dogs, and so, tend to decrease H3-norepinephrine 
uptake. However, Love, et al (58), infused .5-2.0 ug/Kg L-norepinephrine 
and found coronary blood flow was increased moderately to greatly. So, 
this would provide a tendancy for a deceptively greater uptake of H3-
norepinephrine in denervated hearts secondary to increased perfusion. 
In summary, the contribution of perfusion to the results of this 
study is an important problem that remains uncontrolled and quantita-
tively unassessed. However. the SA nodal region would be expected to 
be relatively high in radioactivity by virtue of a copius blood supply. 
,, 
t 
I 
' 
' t 
I 
I 
I 
I 
I 
47 
This was not indicated by this study. Furthermore, the right atrial free 
wall and interatrial septum have been reported to have similar flows. 
This study shows a significant difference in radioactivity between the 
two, which, again~ is inconsistent with the event of perfusion having 
a major role in differential radiolabel distribution. The denervated 
hearts might be expected to have altered coronary flow which introduces 
a confounding. 
In the denervated hearts, uptake was reduced to 23 percent of normal. 
Estimates of uptake to 20 percent of control in denervated organs have 
been reported. The present unexpectedly high uptake could be due to 
residual innervation, coronary flow changes after denervation, coronary 
flow changes secondary to supersensitivity to norepinephrine. Since the 
distribution of label was homogenous, this is an indication that residual 
innervation was not responsible because it is unlikely that the surgical 
procedure would proportionally reduce the innervation everywhere in the 
right atrium. 
Within the neural component of the uptake process, there is pos-
sible regional variability of basal sympathetic nerve activity. This 
may influence the uptake of H3-norepinephrine so that the distribution 
of label does not reflect sympathetic nerve density alone. As discussed 
previously, there is an increase in uptake after nerve stimulation. Also, 
secretion of transmitter does not interfere with the uptake process. So, 
nerves with higher activities would be expected to take up more H3-norepi-
nephrine. However, retention of the label would be less in these ter-
minals because nerve stimulation causes release of transmitter and it 
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appears that newly taken up norepinephrine is preferentially released. 
Whether exocytosis is the sole mechanism of norepinephrine release in 
peripheral nerves is unresolved. However, most investigators presently 
feel that it is because exocytosis is the proven mechanism of release in 
adrenal granules. The uptake into the granule has a half time of twenty 
minutes while that into the nerve terminal is only five minutes. The 
uptake process requires uptake into the terminal before uptake into the 
granule. Since the dogs in this study were sacrificed twenty minutes after 
H3-norepinephrine injection~ a greater portion of the H3-norepinephrine 
would not have been bound in the granule but may be bound in the axo-
plasm. Thus, if sympathetic nerve activity in a particular area is 
higher, there would tend to be more label there by virtue of the im-
balance between uptake and secretion. In this way, regional differences 
in sympathetic nerve activity could influence the distribution of the 
1 abe 1. 
One of the assumptions inherent in the application of this tech-
nique is that all sympathetic nerve terminals are created equal. That 
is, that independent of variations in sympathetic nerve activity, all 
sympathetic nerve terminals will take up equal amounts of H3-norepinephrine, 
and they will retain equal amounts of H3-norepinephrine once they have 
taken it up. It is assumed that there are no unknown structural dif-
ferences from terminal to terminal that would affect turnover rates or 
the uptake mechanism. This means, too, that the proportion of H3-
norepinephrine that is metabolized intraneuronally should be equal in 
every sympathetic nerve terminal. The method would also be valid, as 
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it is applied in this study, if there were a random distribution of such 
terminal variations. 
Another assumption that is made is that all sympathetic nerve ter-
minals have the same access to the H3-norepinephrine. That is, they 
are equal distances from equal concentrations of H3-norepinephrine so 
that they a 11 have the same 11 0pportun ity 11 to take up equa 1 amounts of 
H3-norepinephrine. Again, if this factor is random over the heart, the 
technique as it is applied is valid. 
Caution must be taken in the interpretation of comparisons of the 
SA nodal region with the remaining regions. Because the node itself 
is a small fraction of the tissue in the sample, a false impression of 
SA nodal sympathetic supply may be given. Based upon dimensions of 
5 mm3 (48), the SA node is about 5 percent of the volume of the whole 
sample (10 mm x 5 mm x 2 mm = 100 mm3). If Section 4 is taken as rep-
resentative of the extranodal tissue in the SA nodal region, and 5 per-
cent of the counts there are subtracted from the mean (79,800 DPM/g), 
75,810 DPM/g is obtained. If the 5 percent volume that was subtracted 
is replaced by a sample of the same volume that is 1.4. times as densely 
innervated (112,518 DPM/g), the regional DPM/g becomes 81,436. The es-
timate of 1.41 times is obtained from chemical estimates of SA node and 
remaining atrium in studies that report significantly higher norepi-
nephrine content in the SA node than surrounding tissue (78). This 
elevation would not be a significant one. So, although no significant 
elevation in the SA node immediately surrounding tissue is seen in this 
study, the possibility of a very real concentration of sympathetic nerve 
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terminals within the SA node cannot be ruled out. 
The interpretation of the meaning of the apparently distinctly low 
proportion of sympathetic innervation of the interatrial septum must also 
be made carefully. The interatrial septum is decidedly thicker than any 
of the other sections studied. This, of course, influences the density 
of sympathetic nerve terminals. It must be remembered that the data are 
related to volume, and so, do not necessarily reflect the absolute num-
ber of nerve terminals present when sample thickness varies. The in-
teratrial septum may have the same number of sympathetic nerve terminals 
toward its right atrial surface as adjoining right atrium. For example, 
assume the interatrial septum is three times as thick as the other walls 
of the right atrium, and that the overwhelming abundance of sympathetic 
nerve terminals is confined to the outer thirds of the septum. Then, 
the right atrial third of Section 13 (mean = 695 DPM/100 mg) would have 
3/2 of the counts seen, or 1042 DPM/100 mg, which is comparable to the 
lower anterior free wall and the dorsal free wall. So, although this 
study finds a low density of sympathetic nerve terminals in the inter-
atrial septum, this does not necessarily mean that there are fewer nerve 
terminals there than in the other adjoining walls of the right atrium. 
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CHAPTER VI 
CONCLUSIONS 
Under the assumption that uptake of H3-norepinephrine in the right 
atrium is a function of the adrenergic innervation only, it is concluded 
that the tip of the dog right atrial appendage has a significantly higher 
density of sympathetic nerve terminals when compared to the rest of the 
atrium. Unexpectedly, the region containing the SA node was not sig-
nificantly higher in sympathetic nerve density than any section of right 
atrium and was, in fact, lower than part of the appendage. Because dif-
ferences in sympathetic innervation do exist within the atrium, care 
must be taken to describe the exact location of samples when comparisons 
are made. Furthermore, since the results of any comparison will be de-
pendent upon the size of the sample, as well as the location, caution 
must be used in the interpretation and application of such comparisons. 
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APPENDIX I 
TABLE A 
NOREPINEPHRINE UPTAKE IN CONTROL DOG RIGHT ATRIUM 
Section Dog ( DPM/ g) 
1 2 3 4 5 6 7 8 9 10 
1 87,965 74,125 162,445 172,525 147,865 109,865 215,600 88,500 173,560 127,345 
(99) ( 1 00) ( 100) (100) ( 100) (90) ( 100) (90) (85) ( 100) 
2 88,735 68,785 124 '165 115,715 93,655 109,525 196 ,600 79,995 142,915 103,215 
( 100) (93) (76) (67) ( 63) (89) ( 91 ) ( 81) (70) (81) 
3 73,440 51 ,045 89,430 79,910 77,090 100,905 68 '115 127,503 88,020 
(83) (69) (55) ( 46) (52) (83) ( 60) (63) ( 69) 
4 65,225 46,940 100,885 65,800 47,540 96,540 110,865 70 '120 114,395 79 ,615 
(74) (63) (62) (38) (32) (72) (51) (71) (56) (63) 
5 60,300 44,920 113,975 51 ,650 46 ,930 107,990 125,340 54,520 155,690 59 ,450 
(68) ( 61 ) (70) (30) (32) ( 88) (58) (55) (77) ( 47) 
6 79 '110 11,700 60 '795 59,240 43,525 121 ,990 94,890 98,360 109,995 85,050 
(86) ( 16) (37) (34) (29) (1 00) (44) ( 100) (54) ( 67) 
7 37,370 36,725 32,930 33,775 43,620 67,735 64,305 58,540 75,550 63,715 
(42) (50) (20) (20) (29) (56) (30) (60) (37) (50) 
Top figure is radioactivity in DPM/g. The expression of this as percent of maximum is indicated 
in parentheses. 
0"1 
--' 
APPENDIX I (CONTINUED) 
Section Dog ( DPM/ g) 
2 3 4 5 6 7 8 9 10 
8 52,910 40,360 65,730 33,665 55,650 67,520 146,720 62,900 69,370 88,555 (60) (54) ( 40) (20) (39) (55) (68) (64) ( 34) (70) 
9 41,140 40 '770 58,875 33,935 44,315 58,410 64,660 50 ,21 5 90,865 67 ,825 (46) (55) (36) (20) (30) (48) ( 30) (51) ( 45) (53) 
10 44,220 38,010 45 '130 42,775 50,445 60,325 73,280 52,915 70,225 42,885 (50) (51) (28) (25) ( 34) (50) ( 34) (54) ( 35) (34) 
11 30,395 33,615 31 ,995 33,505 37,550 36,340 52 ,580 42 ,580 73,525 37 '170 ( 34) (45) (20) (19) (25) ( 30) (24) ( 43) (36) (29) 
12 26,970 41,295 32,430 24,535 35,950 40 '735 55,990 57,350 40,285 (30) (56) (29) ( 14) (24) ( 33) {57) ( 28) (32) 
13 25,070 38 '120 31 ,475 29,900 36,435 38,090 33,875 37,020 42,585 35,020 (28) (51) ( 19) ( 17) (25) (31) (16) ( 38) (21) (28) 
14 29,200 40,970 31 ,410 28,200 37,085 36,175 50 ,395 35,535 50 ,025 35,205 (33) (55) ( 19) ( 16) (25) ( 30) (23) (36) (25) (28) 
15 44,265 42,630 34,385 35,630 36,660 51 '720 47,590 29,555 51 ,375 31 ,320 (50) (58) (21) (21) (25) ( 42) (22) ( 30) (25) (25) 
16 34 ,985 50 ,880 41 ,910 68,360 34,610 69 '170 58,875 70 ,300 (39) ( 69) (26) (40) (23) (57) ( 60) (35) 
0"1 
N 
APPENDIX I (CONTINUED) 
Section Dog (DPM/g) 
1 2 3 4 5 6 
17 29,500 34,355 36,125 36,030 35,760 68 '760 (33) ( 46) (22) ( 21 ) (24) (56) 
18 41 ,430 36,880 37,960 41 '91 5 34 '515 51 '700 ( 47) (50) (23) (24) (23) (42) 
19 69 '110 36,820 122,295 85,810 84,250 88,450 
(78) (50) (75) (50) (57) (73) 
20 79,325 60,700 136,530 140 ,370 109 '190 113,665 ( 89) ( 82) ( 84) (81) (74) (93) 
7 8 
74,390 
(34) 
55,360 
(56) 
83,120 47,745 
( 39) (49) 
156,375 77,205 
(72) (78) 
170,090 90 ,715 
(79) (92) 
9 
129,670 
(64) 
138,865 
( 68) 
199,595 
(98) 
203,335 
(100) 
.. ,·~.·. ,'· 
- ~,~ 
10 
74,330 
(58) 
45,785 
( 36) 
83,480 
(66) 
118,030 
(93) 
0'1 
w 
--~ 
APPENDIX II 
TABLE B 
NOREPINEPHRINE UPTAKE IN DENERVATED DOG RIGHT ATRIUM 
Section Dog ( DP~1/g) 
1 2 3 4 5 6 7 8 
47,920 44,660 15,065 17 ,615 12,825 44,410 31 ,605 13 '1 00 
( 100) ( 83) ( 13) (55) (24) ( 81) ( 74) ( 76) 
2 16 '985 53,815 23,745 19 ,850 35,290 41 ,490 27,855 8,255 
( 35) ( 100) (20) (62) (65) ( 76) (65) ( 48) 
3 12,540 49,215 24 '115 22 ,260 33,060 43,385 9,955 (26) (91) (20) ( 70) ( 61 ) ( 79) (58) 
4 17 '590 36,675 27,735 18 ,305 54,005 46,465 32,235 12,095 
(37) (68) (23) (58) ( 100) ( 85) ( 75) ( 70) 
5 24,555 29 '120 65,375 23,745 51 ,580 40,880 42,720 12 '775 
(51) (54) (55) (75) (96) ( 75) ( 100) (74) 
6 16 '39 5 36,815 57,495 25,690 34,885 41 '155 38,970 13,860 
(34) (68) ( 48) ( 81) (65) ( 75) (91) ( 80) 
7 13 ,335 36,290 51 '155 29,400 31 ,765 28,550 34 ,890 13,550 
(28) ( 67) ( 43) (93) (59) (52) ( 82) ( 78) 
Top figure is radioactivity in DPM/g. The expression of this as percent of maximum is 
indicated in parentheses. 
(J) 
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APPENDIX II ( CONTINUED ) 
Section Dog ( DPM/g) 
1 2 3 4 5 
8 14,225 41,735 119,015 17,980 25,035 
(30) (78) ( 100) (57) ( 46) 
9 10 ,850 34,820 40,645 24,150 31 '59 5 (23) (65) (34) (76 J (59) 
10 11 ,975 31 ,560 58,295 27,470 30 ,995 (25) (59) ( 49) ( 86) (57) 
11 17 '170 32,470 24,425 21 ,280 29,515 
( 36) (60) (21) (67) (55) 
12 12 ,495 42,595 45,795 28,140 15,385 
(26) (79) (38) ( 89) (28) 
13 13,380 44,670 23,960 26,165 41 '385 (29) ( 83) (20) (82) (77) 
14 14 '705 44,145 27,970 31 '765 45,870 
( 31 ) (82) (23) ( 100) (85) 
15 13.335 43,730 22,795 27,620 29,670 
(28) (81) (19) (87) (55) 
6 7 
35,375 33,205 
(65) ( 78) 
31 ,635 31 ,860 
(58) ( 75) 
33 '1 55 32,305 
(60) ( 76) 
32 ,705 33,690 
(60) ( 79) 
38,460 25,595 
( 70) ( 60) 
33,675 31 ,860 . 
( 61 ) ( 75) 
31 ,205 33,245 
(57) ( 78) 
35,740 42,295 
(65) (99) 
. _ ., 
~ 
8 
13,930 
( 81 ) 
11 '72 5 
( 68) 
14,235 
( 82) 
13 '370 
(77) 
15,220 
( 88) 
16,245 
(94) 
17,325 
(100) 
14 ,455 
( 84) 
0) 
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APPENDIX I I {CONTINUED) 
Section Dog ((DPM/g) 
1 2 3 4 
16 15,215 39 ,965 27,560 28,765 (32) (74) (23) (91) 
17 14,895 27 '780 22,940 23,900 (31) (52) ( 19) (75) 
18 14,055 34 ,910 17,610 16,115 (29) (65) ( 15) (51) 
19 17,980 43,565 20,005 22,855 (38) (81) ( 17) (72) 
20 18,780 40 '155 22,785 14,685 (39) (75( (19) ( 46) 
5 6 
44,370 44 ,610 (82) {81) 
45,305 41 ,355 
( 84) { 75) 
33,990 31 ,835 (63) {58) 
32,615 43,125 
(60) ( 79) 
28,960 54,815 
(54) (100) 
7 
30,955 
( 72) 
31 ,600 
{ 74) 
37,665 
{ 88) 
15,875 
( 37) 
26,500 
(62) 
•••• ·.· 1 
8 
13,410 
( 77) 
13 '300 
( 77) 
11 ,990 
(69) 
11 '180 
{ 65) 
14,860 
(86) 
0'1 
0'1 
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